Atlas Trials

Rifampicin vs Rifabutin in HIV/AIDS Patients Combined With Tuberculosis

Clinical trial NCT03478033 · UNKNOWN

Trial details

NCT number
NCT03478033
Sponsor
Shanghai Public Health Clinical Center
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Tuberculosis, PulmonaryAIDS
Start date
2018-04-15
Primary completion
2020-06-01
Enrollment
230

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.